Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2738-2741

  Fraser, Susan L ^a   Jorgensen, James H ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFEPIME; CHLORAMPHENICOL DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINAFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DOXYCYCLINE; EPEREZOLID; ERYTHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINCOMYCIN; LINEZOLID; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; QUINUPRISTIN; RIFAMPICIN; SPARFLOXACIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CLASSIFICATION; DRUG EFFICACY; FLAVOBACTERIUM; NONHUMAN; PRIORITY JOURNAL;

EID: 0030734868     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2738     Document Type: Article

References (29)

1. Aber, R. C., C. Wennersten, and R. C. Moellering, Jr. 1978. Antimicrobial susceptibility of flavobacteria. Antimicrob. Agents Chemother. 14:483-487.
2. Altmann, G., and B. Bogokovsky. 1971. In-vitro sensitivity of Flavobacterium meningosepticum to antimicrobial agents. J. Med. Microbiol. 4:296-299.
3. Appelbaum, P. C., S. K. Spangler, and T. Tamarree. 1988. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin. Chemotherapy (Basel) 34:40-45.
4. Bachman, K. H., D. L. Sewell, and L. J. Strausbaugh. 1996. Recurrent cellulitis and bacteremia caused by Flavobacterium odoratum. Clin. Infect. Dis. 22:1112-1113.
5. Blahová, J., M. Hupková, V. Kreméry, and K. Kubonová. 1994. Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningosepticum. Eur. J. Clin. Microbiol. Infect. Dis. 13:833.
6. Bloch, K. C., R. Nadarajah, and R. Jacobs. 1997. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Medicine (Baltimore) 76:30-41.
7. Bolash, N. K., and H. H. Liu. 1995. Quinolone susceptibility of multiply-resistant Flavobacterium meningosepticum clinical isolates in one urban hospital. Drugs 49:168-170.
8. Bruun, B. 1987. Antimicrobial susceptibility of Flavobacterium meningosepticum strains identified by DNA-DNA hybridization. Acta Pathol. Microbiol. Immunol. Scand. 95:95-101.
9. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosu to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
10. Ferrer, C., E. Jakob, G. Pastorino, and L. I. Juncos. 1995. Right-sided bacterial endocarditis due to Flavobacterium odoratum in a patient on chronic hemodialysis. Am. J. Nephrol. 15:82-84.
11. George, R. M., C. P. Cochran, and W. E. Wheeler. 1961. Epidemic meningitis of the newborn caused by flavobacteria. Am. J. Dis. Child. 101:296-304.
12. Holmes, B., J. J. Snell, and S. P. Lapage. 1979. Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents. J. Clin. Pathol. 32:73-77.
13. Hsueh, P.-R., T.-R. Hsiue, J.-J. Wu, L.-J. Teng, S.-W. Ho, W.-C. Hsieh, and K.-T. Luh. 1996. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin. Infect. Dis. 23:550-555.
14. Hsueh, P.-R., J.-J. Wu, T.-R. Hsiue, and W.-C. Hsieh. 1995. Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin. Infect. Dis. 21:1337-1338.
15. Igari, J., T. Oguri, and T. Higuchi. 1994. Evaluation of minocycline and cefuzonam for antimicrobial activity against clinical isolates. Jpn. J. Antibiot. 47:1013-1029.
16. Jorgensen, J. H., L. A. Maher, and A. W. Howell. 1991. Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrob. Agents Chemother. 35:2410-2414.
17. Korzets, Z., M. C. Maayan, and J. Bernheim. 1995. Flavobacterial peritonitis in patients treated by peritoneal dialysis. Nephrol. Dial. Transplant. 10:280-283.
18. Lee, E. L., M. J. Robinson, M. L. Thong, S. D. Puthucheary, T. H. Ong, and K. K. Ng. 1977. Intraventricular chemotherapy in neonatal meningitis. J. Pediatr. 91:991-995.
19. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. Olsen, H. 1967. An in vitro study of the antibiotic sensitivity of Flavobacterium meningosepticum. Acta Pathol. Microbiol. Scand. 70:601-612.
21. Olsen, H., and T. Ravn. 1971. Flavobacterium meningosepticum isolated from the genitals. Acta Pathol. Microbiol. Scand. 79:102-106.
22. Reinarz, J. A., B. B. Mays, and J. P. Sanford. 1964. In vitro sensitivity determinations on Herellea and Flavobacterium species. Antimicrob. Agents Chemother. 4:451-456.
23. Sader, H. S., R. N. Jones, and M. A. Pfaller. 1995. Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis. Clin. Infect. Dis. 21:997-1000.
24. Sanford, J. P., D. N. Gilbert, R. C. Moellering, Jr., and M. A. Sande. 1997. The Sanford guide to antimicrobial therapy, 27th ed. Antimicrobial Therapy, Inc., Vienna, Va.
25. Tizer, K. B., J. S. Cervia, A.-M. Dunn, J. J. Stavola, and G. J. Noel. 1995. Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis. Pediatr. Infect. Dis. J. 14:916-917.
26. Vancanneyt, M., P. Segers, U. Torck, B. Hoste, J.-F. Bernardet, P. Vandamme, and K. Kersters. 1996. Reclassification of Flavobacterium odoratum (Stutzer 1929) strains to a new genus, Myroides, as Myroides odoratus comb. nov. and Myroides odoratiminus sp. nov. Int. J. Syst. Bacteriol. 46:926-932.
27. Vandamme, P., J.-F. Bernardet, P. Segers, K. Kersters, and B. Holmes. 1994. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol. 44:827-831.
28. von Graevenitz, A., and M. Grehn. 1977. Susceptibility studies on Flavobacterium II-b. FEMS Microbiol. Lett. 2:289-292.
29. Yabuuchi, E., T. Ito, E. Tanimura, N. Yamamoto, and A. Ohyama. 1981. In vitro antimicrobial activity of ceftizoxime against glucose-nonfermentative gram-negative rods. Antimicrob. Agents Chemother. 20:136-139.